To view this email as a web page, click here

     
 
 
 
image
 

Dear E,

 

I am pleased to announce our latest round of speakers for the Fierce Biotech Virtual Event Next Gen: What’s beyond the leading edge of biotech and pharma? This series will run virtually June 22-23, 2021.

Join speakers from Novartis, Genentech, Allogene, Bristol Meyers Squibb, LEXEO Therapeutics, AstraZeneca and more for a series of CEO interviews and panel discussions exploring new waves of cancer targets, novel approaches to cell and gene therapies, cutting-edge technologies set to change biopharma manufacturing and a panel discussion around diversity in the biopharma industry.

 

With a strong focus on networking, this year's virtual platform will allow you to facilitate one-to-one video meetings and group chats with speakers, partners, and attendees.

 

 
 
Register
 
 

 

FEATURED SPEAKERS

 
 

Dave Lennon
Novartis Gene Therapies
President

 

R. Nolan Townsend
LEXEO Therapeutics
CEO

 

Kristen Hege
Bristol Myers Squibb
SVP - Early Clinical Development, Oncology/Hematology and Cell Therapy

 
 

Bobby Gaspar, M.D., Ph.D
Orchard Therapeutics
Co-Founder and CEO

 

Eric Rubin, M.D.
Merck Research Labs
SVP & Therapeutic Area Head, Oncology Early Development

 

Pearl Huang
Cygnal Therapeutics
CEO

 
 

Shankar Ramaswamy, M.D.
Kriya Therapeutics
Co-Founder and CEO

 

Alison Moore, Ph.D
Allogene
Chief Technical Officer

 

Camille Hertzka
AstraZeneca
Head of Medical Affairs, US Oncology

 
 
View the Speaking Faculty

 

 
 

 

Thank You to Our Sponsors

 
 

PLATINUM SPONSORS

 
 
 
 
 
 
 

GOLD SPONSORS

 
 
 
   
 
 

SILVER SPONSORS

 
 
     
 
 
 

You are currently subscribed as newsletter@newslettercollector.com
If you no longer wish to receive promotions from Fierce Healthcare, simply unsubscribe.
Refer to our Privacy Policy.

Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
© 2021 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission.